Webinar on the Role of Omega-3 Fatty Acids in Cardiovascular Health – EAS
European Atherosclerosis Society shared a post on LinkedIn:
“The second webinar of the series will explore the latest research on the role of omega – 3 fatty acids in cardiovascular health.
Leading experts will share their insights on how icosapent ethyl and marine omega – 3 fatty acids influence lipoprotein remodeling and cardiovascular disease (CVD) risk markers, especially in normolipidemic individuals.
Maria Cherska, The Head of Cardiology Department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», reposted European Atherosclerosis Society’s post on LinkedIn, adding:
“In this session, leading experts will unpack how icosapent ethyl and marine – derived omega – 3s contribute to lipoprotein remodeling and modulate key cardiovascular risk markers – with particular focus on individuals with normolipidemia.
A valuable discussion for those interested in the evolving science behind residual risk and lipid biology.”
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 4, 2026, 17:38Michael Stark: Greater Improvements in Cerebral Oxygenation With Restrictive Transfusion Thresholds
-
Jul 4, 2026, 17:27Reza Shojaei: How America Won the Plasma Race
-
Jul 4, 2026, 17:26Akshat Jain: The First CRISPR-Cas9 Gene Therapy Approved for Children as Young as 2 with SCD
-
Jul 4, 2026, 17:25Francesca Palandri: Dynamic, Treatment Response-Driven Risk Assessment in Polycythemia Vera
-
Jul 4, 2026, 17:24Thierry Burnouf: The Fragile Supply of Human Hyperimmune Immunoglobulins
-
Jul 4, 2026, 15:41Emmanuel J. Favaloro: New Research Highlights Benchmarks for Low Molecular Weight Heparin Monitoring
-
Jul 4, 2026, 15:38Roshni Kulkarni: Maternal Mortality In Bleeding Disorders
-
Jul 4, 2026, 15:34Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
-
Jul 4, 2026, 15:20Bruno Pougault: Heparin Monitoring Remains One of the Most Challenging Areas in Laboratory Hemostasis